Management of the hypertensive patient with elevated heart rate: Statement of the Second Consensus Conference endorsed by the European Society of Hypertension
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
In June 2015, a panel of experts gathered in a consensus conference to plan updating recommendations on the management of the hypertensive patient with elevated heart rate (HR), previously released in 2006. The issues examined during that meeting and further discussed by the participants during the following months involved the assessment of HR, the relevance of HR as a cardiovascular risk factor, the definition of tachycardia and the treatment of the hypertensive patient with high HR. For the measurement of resting HR the panel experts recommended that scientific investigations focusing on HR should report information on length of resting period before measurement, information about temperature and environment, method of measurement, duration of measurement, number of readings, time interval between measurements, body position and type of observer. According to the panellists there is convincing evidence that HR is an important risk factor for cardiovascular disease and they suggest to routinely include HR measurement in the assessment of the hypertensive patient. Regarding the definition of tachycardia, the panellists acknowledged that in the absence of convincing data any threshold used to define tachycardia is arbitrary. Similarly, as there are no outcome studies of HR lowering in tachycardia hypertension, the panellists could not make practical therapeutic suggestions for the management of such patients. However, the experts remarked that absence of evidence does not mean evidence against the importance of tachycardia as a risk factor for cardiovascular disease and that long-term exposure to a potentially important risk factor may impair the patient's prognosis. The main aims of the present document are to alert researchers and physicians about the importance of measuring HR in hypertensive patients, and to stimulate research to clarify unresolved issues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Garber, C. E., Blissmer, B., Deschenes, M. R., Franklin, B. A., Lamonte, M. J., Lee, I.-M., Nieman, D. C., & Swain, D. P. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318213fefb · Cited by 9,319 · cited 1×
“The American College of Sports Medicine recommends that moderate-to-vigorous activities should be practiced by most healthy adults [81], but low-intensity”
BackgroundThe Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Swedberg, K., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61198-1 · Cited by 2,563 · cited 1×
“Data obtained with the I/f-channel antagonist ivabradine in patients with congestive heart failure have been inconclusive, though there is some indication that the beneficial effect of this drug can be obtained in patients with HR higher than 70–75 bpm [72–74].”
MethodAortic Pulse Wave Velocity Improves Cardiovascular Event Prediction
Ben-Shlomo, Y., Spears, M., Boustred, C., May, M., Anderson, S. G., Benjamin, E. J., Boutouyrie, P., Cameron, J., Chen, C.-H., Cruickshank, J. K., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.063 · Cited by 1,835
Fox, K., Ford, I., Steg, P. G., Tendera, M., & Ferrari, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61170-8 · Cited by 1,099 · cited 1×
“Data obtained with the I/f-channel antagonist ivabradine in patients with congestive heart failure have been inconclusive, though there is some indication that the beneficial effect of this drug can be obtained in patients with HR higher than 70–75 bpm [72–74].”
MethodSelf-citationResting Heart Rate in Cardiovascular Disease
Fox, K., Borer, J. S., Camm, A. J., Danchin, N., Ferrari, R., Lopez Sendon, J. L., Steg, P. G., Tardif, J.-C., Tavazzi, L., & Tendera, M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.079 · Cited by 1,062
Self-citationEuropean Society of Hypertension Practice Guidelines for home blood pressure monitoring
Parati, G., Stergiou, G. S., Asmar, R., Bilo, G., de Leeuw, P., Imai, Y., Kario, K., Lurbe, E., Manolis, A., Mengden, T., et al. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.54 · Cited by 482
Self-citationInfluence of Heart Rate on Mortality in a French Population: Role of Age, Gender, and Blood Pressure
Benetos, A., Rudnichi, A., Thomas, F., Safar, M., & Guize, L. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.44 · Cited by 356 · cited 2×
“In some studies, a flattening of the relationship was found in the individuals of the lower HR quintiles [21,22], but a real upturn in risk for a HR less than 60 bpm was reported only in a minority of studies [36–38].”
BackgroundResultBöhm, M., Borer, J., Ford, I., Gonzalez-Juanatey, J. R., Komajda, M., Lopez-Sendon, J., Reil, J.-C., Swedberg, K., & Tavazzi, L. (2013) · Clinical Research in Cardiology · doi:10.1007/s00392-012-0467-8 · Cited by 248 · cited 1×
“Data obtained with the I/f-channel antagonist ivabradine in patients with congestive heart failure have been inconclusive, though there is some indication that the beneficial effect of this drug can be obtained in patients with HR higher than 70–75 bpm [72–74].”
MethodJulius, S., Palatini, P., Kjeldsen, S. E., Zanchetti, A., Weber, M. A., McInnes, G. T., Brunner, H. R., Mancia, G., Schork, M. A., Hua, T. A., et al. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.10.025 · Cited by 179
Self-citation
Cited by
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Umemura, S., Arima, H., Arima, S., Asayama, K., Dohi, Y., Hirooka, Y., Horio, T., Hoshide, S., Ikeda, S., Ishimitsu, T., et al. (2019) · Hypertension Research · doi:10.1038/s41440-019-0284-9 · Cited by 1,880
“In the current guidelines, therefore, the optimal pulse rate is not defined, but at least routine measurement of pulse rate is recommended for patients with hypertension [210].”
BackgroundJensen, M. T., Treskes, R. W., Caiani, E. G., Casado-Arroyo, R., Cowie, M. R., Dilaveris, P., Duncker, D., Di Rienzo, M., Frederix, I., De Groot, N., et al. (2021) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztab011 · Cited by 93
Self-citationNight-time heart rate nondipping: clinical and prognostic significance in the general population
Cuspidi, C., Facchetti, R., Bombelli, M., Sala, C., Tadic, M., Grassi, G., & Mancia, G. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001703 · Cited by 36
Self-citationHeritability of resting heart rate and association with mortality in middle-aged and elderly twins
Jensen, M. T., Wod, M., Galatius, S., Hjelmborg, J. B., Jensen, G. B., & Christensen, K. (2018) · Heart · doi:10.1136/heartjnl-2016-310986 · Cited by 31
Self-citation
Metadata
- Authors
- Palatini, P., Rosei, E. A., Casiglia, E., Chalmers, J., Ferrari, R., Grassi, G., Inoue, T., Jelakovic, B., Jensen, M. T., Julius, S., Kjeldsen, S. E., Mancia, G., Parati, G., Pauletto, P., Stella, A., & Zanchetti, A.
- Venue
- Journal of Hypertension
- Published
- 2016-05
- Volume
- 34
- Issue
- 5
- Pages
- 813-821
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W2299474693
- Cited by
- 132
- References
- 13
- FWCI
- 13.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Management of the hypertensive patient with elevated heart rate: Statement of the Second Consensus Conference endorsed by the European Society of Hypertension. https://app.cochat.ai/papers/10.1097/hjh.0000000000000865
- The paper
- Palatini, P., Rosei, E. A., Casiglia, E., Chalmers, J., Ferrari, R., Grassi, G., Inoue, T., Jelakovic, B., Jensen, M. T., Julius, S., Kjeldsen, S. E., Mancia, G., Parati, G., Pauletto, P., Stella, A., & Zanchetti, A. (2016). Management of the hypertensive patient with elevated heart rate: Statement of the Second Consensus Conference endorsed by the European Society of Hypertension. Journal of Hypertension. https://doi.org/10.1097/hjh.0000000000000865
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.